FACIT
FACIT is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed FACIT Information
Geographic Data
Address: MaRS Centre 661 University Avenue Suite 510
City: Toronto
State: ontario
Zip: M5G 0A3
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
FACIT is a commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted over $850 million in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province&s;s investment in research and healthcare to the benefit of the local economy and patients worldwide.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | QurCan Therapeutics Inc. | Seed Round | 3M |
| 4/2019 | QurCan Therapeutics Inc. | Seed Round | - |
| 10/2019 | Cellular Analytics | Seed Round | - |
| 7/2017 | Radialis Medical | Venture Round | - |
| 1/2016 | CapNostics | Venture Round | - |
| 8/2017 | DNAstack | Pre Seed Round | - |
| 2/2018 | 16 Bit | Pre Seed Round | 450k |
| 9/2018 | Talon Pharmaceuticals | Venture Round | - |
| 1/2020 | Xpan | Seed Round | - |
| 1/2020 | QurCan Therapeutics Inc. | Seed Round | - |
| 1/2019 | DNAstack | Pre Seed Round | - |
| 1/2017 | KA Imaging | Seed Round | 1.5M |
| 4/2018 | Polumiros | Grant | 50k |
| 7/2017 | Radialis | Grant | 155.1k |
| 2/2020 | bridge7 | Seed Round | - |
| 4/2023 | Radiant Biotherapeutics | Seed Round | 0 |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 6/2020 | Replica Analytics | Seed Round | 0 |
| 1/2013 | Triphase Accelerator Corporation | Venture Round | - |
| 7/2014 | Privacy Analytics | Seed Round | 3.5M |
| 10/2015 | Turnstone Biologics | Series A | 11.3M |
| 3/2017 | Propellon Therapeutics | Seed Round | 3M |
| 11/2016 | Turnstone Biologics | Series B | 0 |
| 2/2018 | Dalriada Therapeutics | Seed Round | - |
| 5/2021 | QurCan Therapeutics Inc. | Seed Round | 0 |
| 6/2020 | Replica Analytics | Seed Round | 0 |
| 2/2020 | bridge7 | Seed Round | - |
| 1/2020 | Xpan | Seed Round | - |
| 1/2020 | QurCan Therapeutics Inc. | Seed Round | - |
| 10/2019 | Cellular Analytics | Seed Round | - |
| 4/2019 | QurCan Therapeutics Inc. | Seed Round | - |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 1/2019 | DNAstack | Pre Seed Round | - |
| 9/2018 | Talon Pharmaceuticals | Venture Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
